302 EAST PETTIGREW STREET, DURHAM, NC
Commences Dosing in Phase 1/2 FUNCTION-DMD Study
Reports Second Quarter 2026 Financial Results and Provides Business Update
Changes in Board, Management or Compensation, Reg. FD
News
First Amendment to Loan Agreement Extends Maturity Date to 2029
Announces New and Late-Breaking PBGENE-HBV Clinical Data from the ELIMINATE-B Study at European Association for the Study of the Liver Congress 2026
Approval of Amended 2019 Incentive Award Plan at Annual Meeting
Reports First Quarter 2026 Financial Results and Provides Business Update
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Free Writing Prospectus